SCHEMBL5730706

SCHEMBL5730706

Cc1cc(-c2ccc(F)cc2)nc2sc(OC(N)=O)c(N)c12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.52
KMT2A Q03164 1/20 0.52
MAPT P10636 6/20 0.49
KDM4E B2RXH2 6/20 0.49
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
FOXM1 Q08050 1/20 0.44
CHRM4 P08173 2/20 0.43
RXFP1 Q9HBX9 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
TP53 P04637 1/20 0.42
POLB P06746 1/20 0.42
LIMK1 P53667 2/20 0.42
HPGD P15428 3/20 0.42
LMNA P02545 1/20 0.42
IKBKB O14920 2/20 0.41
CHUK O15111 1/20 0.41
PRKACA P17612 1/20 0.41
PRKACG P22612 1/20 0.41
PRKACB P22694 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5742012 0.91 MEN1 (0.54) MEN1KMT2AMAPTKDM4ENPC1
SCHEMBL5739770 0.88 MEN1 (0.52) MEN1KMT2AMAPTKDM4ECHRM4
SCHEMBL5739582 0.88 MEN1 (0.52) MEN1KMT2AMAPTKDM4ENPC1
SCHEMBL5729872 0.88 MEN1 (0.67) MEN1KMT2AMAPTKDM4ENPC1
SCHEMBL6111088 0.88 MEN1 (0.49) MEN1KMT2AMAPTNPC1FOXM1
SCHEMBL5731048 0.87 LIMK1 (0.56) MEN1KMT2AMAPTKDM4ENPC1
SCHEMBL5740127 0.86 MEN1 (0.50) MEN1KMT2AMAPTKDM4ECHRM4
SCHEMBL2851062 0.85 PIM1 (0.55) MEN1KMT2AMAPTKDM4ENPC1
SCHEMBL5740222 0.84 MEN1 (0.48) MEN1KMT2AMAPTKDM4ECHRM4
SCHEMBL5740675 0.84 MEN1 (0.56) MEN1KMT2AMAPTKDM4ECHRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006074919-A2 3-AMINO-6-ARYL(OR 6-HETEROARYL)-THIENO[2,3-B]PYRIDIN-2-CARBOXAMIDES, PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME AND THEIR USE AS TNFα INHIBITORS CURACYTE DISCOVERY GMBH (DE) 2006-07-20 WO claimed
EP-1681292-A1 3-Amino-6-aryl(or 6-heteroaryl)-thieno¬2,3-b|pyridin-2-carboxylic acid amides, pharmaceutical compositions comprising the said and their use as inhibitors of TNFalpha release IBFB Pharma GmbH (DE) 2006-07-19 EP claimed
WO-2006074919-A2 3-AMINO-6-ARYL(OR 6-HETEROARYL)-THIENO[2,3-B]PYRIDIN-2-CARBOXAMIDES, PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME AND THEIR USE AS TNFα INHIBITORS CURACYTE DISCOVERY GMBH (DE) 2006-07-20 WO disclosed
EP-1681292-A1 3-Amino-6-aryl(or 6-heteroaryl)-thieno¬2,3-b|pyridin-2-carboxylic acid amides, pharmaceutical compositions comprising the said and their use as inhibitors of TNFalpha release IBFB Pharma GmbH (DE) 2006-07-19 EP disclosed
EP-1619197-A1 Substituted Pyrido[3',2':4,5]thieno[3,2-d]pyrimidin-2,4(1H,3H)diones and -4(3H)ones as well as Pyrido[3',2':4,5]furo[3,2-d]-pyrimidin-2,4(1H,3H)diones und -4(3H)ones as inhibitors of TNF-alpha release Curacyte Discovery GmbH (DE) 2006-01-25 EP disclosed